- Will Trump say "R&D" or "Research and Development" during healthcare affordability announcement?100¢
- Will Trump say "Neurocrine" during healthcare affordability announcement?0¢
- Will Trump say "Failing Nation" or "Failing Country" during healthcare affordability announcement?0¢
- Will Trump say "Protester" during healthcare affordability announcement?0¢
- Will Trump say "Madrigal" during healthcare affordability announcement?0¢
- Will Trump say "Psychiatric" or "Psychedelic" during healthcare affordability announcement?0¢
- Will Trump say "London" during healthcare affordability announcement?100¢
- Will Trump say "Middleman" or "Middle Man" during healthcare affordability announcement?0¢
- Will Trump say "Rare" or "Chronic" during healthcare affordability announcement?100¢
- Will Trump say "Obama" during healthcare affordability announcement?0¢
- Will Trump say "Kharg" or "Island" during healthcare affordability announcement?0¢
- Will Trump say "Minesweeper" or "Mine Dropper" during healthcare affordability announcement?0¢
Donald Trump is scheduled to make an announcement on healthcare affordability in the Oval Office on August 31, 2026 at 3PM ET (https://rollcall.com/factbase/trump/calendar/). This market will resolve to "Yes" if Donald Trump says the listed term during the specified appearance. Otherwise, the market will resolve to "No". This market is explicitly about Trump's announcement on healthcare affordability in the Oval Office on August 31, 2026 (https://rollcall.com/factbase/trump/calendar/). Speeches, events, or comments that occur outside of the named, scheduled event will not qualify toward this market's resolution. If this event is definitively cancelled, or otherwise is not available by September 1, 2026, 11:59 PM ET, "-No Qualifying Event-" will resolve to "Yes" and all other brackets will resolve to "No". The resolution source will be audio/video of the event. For full rules, see: https://polymarket-upload.s3.us-east-2.amazonaws.com/market_products/Mentions/Event+Mentions+Contract+DeFi.pdf
Trump’s August 31 Oval Office announcement centers on new Most-Favored-Nation drug pricing agreements with additional manufacturers, extending the administration’s TrumpRx platform and prior deals that have produced the steepest prescription drug price declines in over six decades. The event builds directly on the January 2026 unveiling of the Great Healthcare Plan, which seeks to codify MFN benchmarks, redirect ACA subsidies to enrollees, increase price transparency, and expand over-the-counter access. Traders focus on recurring rhetorical patterns from earlier remarks—references to specific countries or companies involved in pricing disparities, critiques of prior policies, and emphasis on patient savings—while the market awaits confirmation of any last-minute deal details or phrasing that could trigger specific resolution outcomes.